Eli Lilly and Co (NYSE: LLY) has outperformed the market over the past 5 years by 25.43% on an annualized basis producing an average annual return of 37.44%. Currently, Eli Lilly and Co has a market ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Wall Street on Friday ended a listless day with marginal losses, with the session echoing the overall movement seen this week ...

Eli Lilly (LLY) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

Although the stock is trading at a premium valuation, the company’s outstanding operational performance, strong financial ...

AI chipmaker Nvidia ( NVDA) and pharmaceutical giant Eli Lilly ( LLY) on Monday announced that the two companies will jointly ...

Healthcare investing offers defensive characteristics during market turbulence, yet regulatory uncertainty and political risk ...

As part of the collaboration, Lilly and Revvity will jointly fund access for selected participants, including access to Signals One and Signals Xynthetica software offerings and modeling credits. This ...

Wall Street's main indexes showed mixed performance as the Dow fell and the Nasdaq rose. Investors are cautious, awaiting the ...

Wall Street’s main indexes were mixed on Wednesday, with the S&P 500 and the Dow coming off their intraday record highs after ...

Eli Lilly shares surged over 4.5% on analyst upgrades, acquisition rumors involving Ventyx Biosciences, and a new $1.3 ...